November 1, 2007
Seaport World Trade Center
Boston, Massachusetts
The iSBTc Primer provides an overview of tumor immunology and biological therapy by leaders in the field, and seeks to educate students, post-doctoral fellows, clinical residents and fellows, as well as junior faculty regarding both the biologic underpinnings of the field, as well as recent basic science and clinical developments.
| Martin A. Cheever, MD Fred Hutchinson Cancer Research Center |
Kim A. Margolin, MD City of Hope Cancer Center |
| Judah Folkman, MD Children's Hospital Boston |
Patrick Hwu, MD MD Anderson Cancer Center |
| Rakesh K. Jain, PhD Harvard Medical School |
Kim A. Margolin, MD City of Hope Cancer Center |
| Francesco Marincola, MD National Institutes of Health |
Polly Matzinger, PhD National Institute of Allergy and Infectious Diseases |
| Ira H. Pastan, MD National Institutes of Health |
Kenneth Rock, MD University of Massachusetts Medical School |
| Carmen Scheibenbogen, MD Institut für Med. Immunologie, Charité, Berlin |
Paul M. Sondel, MD, PhD University of Wisconsin |
| Louis M. Weiner, MD Fox Chase Cancer Center |
|
